612
Can. J. Chem. Vol. 83, 2005
matography (10% acetone–CH2Cl2) gave the corresponding
phosphinylamines (70 mg, 93% yield) as a white solid.
HPLC analysis indicated 90.5% ee. (Daicel Chiralcel OD,
hexane : isopropyl alcohol, 90:10, 1.0 mL/min, 220 nm; Rt =
5.3 min (R), 6.7 min (S)). The product spectral data matched
previously reported spectral data.
(7.6 mL) and stirred at rt for 0.5 h. PMHS (2.4 mL,
40 mmol) was then added dropwise to the mixture via sy-
ringe. To a 2–5 mL Emry’s Optimizer glass vessel, flame
dried and purged with argon, was added 4-phenylfuran-
2(5H)-one (80 mg, 0.50 mmol), CuH catalyst solution
(0.5 mL), and t-BuOH (0.06 mL, 0.60 mmol). This solution
was immediately transferred to the microwave and heated at
80 °C for 30 min. The reaction was quenched by diluting
with ether (3 mL), followed by aqueous NaHCO3 (3 mL),
and then allowed to stir at rt for 0.5 h. The product lactone
(75 mg, 93%) was isolated as a white solid; Chiral GC using
a Chiraldex G-TA column with 160 °C isotherm showed
98.6% ee, Rt = 74.01 (minor) and 75.00 (major). The prod-
uct matched previously reported spectral data (8e).
(S)-Ethyl 3-phenylbutanoate (9; Table 2, entry 1)
To a 2–5 mL Emry’s Optimizer glass vessel, flame dried
and purged with argon, was added (E)-ethyl 3-methyl-5-
phenylpent-2-enoate (neat, 0.380 mg, 2 mmol). (DTBM-
SEGPHOS)CuH in
a Bottle (2 mL, 0.001 mol/L,
0.002 mmol) was added via syringe followed by t-BuOH
(230 µL, 2.4 mmol), and the reaction was immediately taken
to the Emry’s Optimizer. The following conditions were ap-
plied: temperature, 60 °C; time, 1200 s; fixed hold time, on;
sample absorption, normal. The TLC (9:1, hexanes:Et2O)
showed complete consumption of starting material. The re-
action was quenched by diluting with THF (3 mL), followed
by aqueous NaOH (2 mL, 3 mol/L), and was allowed to stir
at rt for 2 h. The residue was purified by column chromatog-
raphy and isolated (338 mg, 88% yield) as a clear oil; Chiral
GC using a Chiraldex G-TA column with 100 °C isotherm
showed 97.2% ee, Rt = 77.79 (minor) and 78.70 (major).
The product spectral data matched previously reported spec-
tral data (8e).
4-Phenylpentan-2-one (B, Table 2, entry 4)
To a 25 mL round-bottom flask, flame dried and purged
under argon, was added CuCl (10 mg, 0.10 mmol), NaO-t-
Bu (9.7 mg, 0.10 mmol), and (R,S)-PPF-P(t-Bu)2 JOSIPHOS
(5.2 mg, 0.01 mmol) under an argon atmosphere. The flask
was sealed with a rubber septum and toluene (8.7 mL, dried
through a column of alumina and degassed via 3 freeze–
thaw cycles) was added with a dry glass syringe. The solu-
tion was stirred at rt for 45 min, at which point PMHS
(1.3 mL, 0.73 mmol) was added. After 15 min of stirring,
0.87 mL of the solution was transferred via syringe to an
Emry’s Optimizer glass vessel (sealed and under argon) con-
taining a dry stir bar and 4-phenylpent-3-en-2-one (A,
140 mg, 0.87 mmol). t-BuOH (0.1 mL, 1.05 mmol) was
added, and the vial was immediately taken to the Emry’s
Optimizer. The following conditions were applied: tempera-
ture, 60 °C; time, 1500 s; fixed hold time, on. Upon ejection
of the reaction vial from the optimizer, the septum was re-
moved, and the reaction mixture poured into sat. NaHCO3
(15 mL), where it was stirred for 3 h. The organic layer was
extracted with diethyl ether (3 × 15 mL), washed with brine
(1 × 15 mL), dried over anhydrous Na2SO4, and concen-
trated under reduced pressure. Purification via silica gel
chromatography (20 g, 5% Et2O in hexanes) yielded a clear
oil (124 mg, 87% yield). Chiral GC using a Chiraldex G-TA
column with 100 °C isotherm showed 93.5% ee, Rt = 51.40
(minor) and 53.00 (major). IR (neat) (cm–1): 3035, 2964,
2927, 1716, 1495, 1358, 760, 700. 1H NMR (400 MHz,
CDCl3) δ: 7.28–7.35 (m, 2H), 7.18–7.25 (m, 3H), 3.27–3.38
(m, 1H), 2.68 and 2.76 (dd, J = 6.4 Hz, 2H), 2.08 (s, 3H),
1.28 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ:
22.17, 30.75, 35.58, 52.13, 126.48, 126.92, 128.71, 146.44,
208.08. EI-MS m/z (%): 162 ([M]+, 52), 147(81), 119(16),
105(100), 91(47), 77(29), 51(17). HR-EI-MS calcd. for
C11H14O: 162.1044; found 162.1051.
(S)-Ethyl 3-methyl-5-phenylpentanoate (Table 2, entry 2)
To a 25 mL round-bottom flask, flame dried and purged
under argon, was added CuCl (4.2 mg, 0.042 mmol), NaO-t-
Bu (3.7 mg, 0.039 mmol), and (R)-DTBM-SEGPHOS (3,
4.7 mg, 0.004 mmol) under an argon atmosphere. The flask
was sealed with a rubber septum, and toluene (3.5 mL, dried
through a column of alumina and degassed via 3 freeze–
thaw cycles) was added with a dry glass syringe. The solu-
tion was stirred at rt for 45 min, at which point PMHS
(0.5 mL, 0.279 mmol) was added. After 15 min of stirring,
1 mL of the solution was transferred via syringe to an
Emry’s Optimizer glass vial (sealed and argon purged) con-
taining a dry stir bar and ethyl 3-methyl-5-phenylpent-2-
enoate (218 mg, 1.0 mmol). t-BuOH (0.11 mL, 1.2 mmol)
was added, and the vial was immediately taken to the
Emry’s Optimizer. The following conditions were applied:
temperature, 60 °C; time, 1500 s; fixed hold time, on. Upon
ejection of the reaction vial from the optimizer, the septum
was removed and the reaction mixture poured into sat.
NaHCO3 (15 mL), where it was stirred for 4 h. The organic
layer was extracted with diethyl ether (3 × 15 mL), washed
with brine (1 × 15 mL), dried over anhydrous Na2SO4, and
then concentrated under reduced pressure. Purification via
silica gel chromatography (10 g, 2.5% Et2O in hexanes)
yielded a clear oil (206 mg, 93.6% yield). Chiral GC using a
Chiraldex G-TA column with 95 °C isotherm showed 94.6%
ee, Rt = 277.00 (minor) and 279.46 (major). The product
spectra matched previously reported spectral data (8e).
(R)-N-(1-(4-Trifluoromethylphenyl)ethyl) bis(3,5-
dimethylphenyl)phosphinamide (Table 2, entry 5)
CuCl (3.6 mg, 0.036 mmol), NaOMe (2.0 mg,
0.038 mmol), and (R)-DTBM-SEGPHOS (3, 42.6 mg,
0.036 mmol) were placed into a flame-dried, argon-purged
round-bottom flask (RBF). Toluene (1.5 mL) was added to
the RBF, and the resulting mixture was stirred at rt for 30–
40 min. Meanwhile, N-(1-(4-trifluoromethylphenyl)ethyl-
idene) bis(3,5-dimethylphenyl)phosphinamide (88.6 mg,
0.20 mmol) was added to a 0.5–2.0 mL Emry’s Optimizer
(R)-Dihydro-4-phenyl-(3H)-furan-2-one (Table 2, entry 3)
A
standard solution of (R)-(DTBM-SEGPHOS)CuH
(10 mL, 0.001 mol/L) was prepared as follows:
Cu(OAc)2·H2O (2.0 mg, 0.010 mmol) and (R)-DTBM-
SEGPHOS (11.8 mg, 0.010 mmol) were dissolved in THF
© 2005 NRC Canada